Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Drug Resistance

  Free Subscription


Articles published in Clin Infect Dis

Retrieve available abstracts of 142 articles:
HTML format
Text format



Single Articles


    November 2017
  1. HUMPHRIES RM, Hindler JA, Epson E, Horwich-Scholefield S, et al
    Carbapenem-resistant Enterobacteriaceae (CRE) detection practices in California: What are we missing?
    Clin Infect Dis. 2017 Nov 1. doi: 10.1093.
    PubMed     Text format     Abstract available


    October 2017
  2. TOLEMAN MS, Watkins ER, Williams T, Blane B, et al
    Investigation of a Cluster of Sequence Type 22 Methicillin-Resistant Staphylococcus aureus Transmission in a Community Setting.
    Clin Infect Dis. 2017 Oct 25. doi: 10.1093.
    PubMed     Text format     Abstract available


  3. FARHAT MR, Jacobson KR, Franke MF, Kaur D, et al
    Fluoroquinolone Resistance Mutation Detection Is Equivalent to Culture-Based Drug Sensitivity Testing for Predicting Multidrug-Resistant Tuberculosis Treatment Outcome: A Retrospective Cohort Study.
    Clin Infect Dis. 2017;65:1364-1370.
    PubMed     Text format     Abstract available


  4. ARDAL C, Rottingen JA, Opalska A, Van Hengel AJ, et al
    Pull Incentives for Antibacterial Drug Development: An Analysis by the Transatlantic Task Force on Antimicrobial Resistance.
    Clin Infect Dis. 2017;65:1378-1382.
    PubMed     Text format     Abstract available


    September 2017
  5. SCHROEDER MR, Chancey ST, Thomas S, Kuo WH, et al
    A Population-Based Assessment of the Impact of 7- and 13-Valent Pneumococcal Conjugate Vaccines on Macrolide-Resistant Invasive Pneumococcal Disease: Emergence and Decline of Streptococcus pneumoniae Serotype 19A (CC320) With Dual Macrolide Resistance
    Clin Infect Dis. 2017;65:990-998.
    PubMed     Text format     Abstract available


  6. GURIEVA T, Dautzenberg MJD, Gniadkowski M, Derde LPG, et al
    The transmissibility of antibiotic-resistant Enterobacteriaceae in Intensive Care Units.
    Clin Infect Dis. 2017 Sep 15. doi: 10.1093.
    PubMed     Text format     Abstract available


  7. LEUNG V, Vincent C, Edens T, Miller M, et al
    Antimicrobial resistance gene acquisition and depletion following fecal microbiota transplantation (FMT) for recurrent Clostridium difficile infection.
    Clin Infect Dis. 2017 Sep 15. doi: 10.1093.
    PubMed     Text format     Abstract available


  8. MILES-JAY A, Weissman SJ, Adler AL, Tchesnokova V, et al
    Epidemiology and antimicrobial resistance characteristics of the ST131-H30 subclone among extraintestinal Escherichia coli collected from US children.
    Clin Infect Dis. 2017 Sep 15. doi: 10.1093.
    PubMed     Text format     Abstract available


  9. VAN DUIN D, Lok JJ, Earley M, Cober E, et al
    Colistin vs. Ceftazidime-avibactam in the Treatment of Infections due to Carbapenem-Resistant Enterobacteriaceae.
    Clin Infect Dis. 2017 Sep 4. doi: 10.1093.
    PubMed     Text format     Abstract available


    August 2017
  10. KNIGHT GM, Costelloe C, Murray KA, Robotham JV, et al
    Addressing the unknowns of antimicrobial resistance: quantifying and mapping the drivers of burden.
    Clin Infect Dis. 2017 Aug 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  11. TASHIRO M, Fushimi K, Kawano K, Takazono T, et al
    Comparison of efficacy of antimicrobial agents among hospitalized patients with Mycoplasma pneumoniae pneumonia in Japan during large epidemics of macrolide-resistant M. pneumoniae infections: A nationwide observational study.
    Clin Infect Dis. 2017 Aug 16. doi: 10.1093.
    PubMed     Text format     Abstract available


  12. ABAT C, Rolain JM, Dubourg G, Fournier PE, et al
    Evaluating the Clinical Burden and Mortality Attributable to Antibiotic Resistance: The Disparity of Empirical Data and Simple Model Estimations.
    Clin Infect Dis. 2017;65.
    PubMed     Text format     Abstract available


  13. MACESIC N, Nelson B, Uhlemann AC
    Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: De Novo or Drug Exposure?
    Clin Infect Dis. 2017;65:702-703.
    PubMed     Text format    


  14. SCHECHTER MC, Bizune D, Kagei M, Machaidze M, et al
    Time to Sputum Culture Conversion and Treatment Outcomes Among Patients with Isoniazid-Resistant Tuberculosis in Atlanta, Georgia.
    Clin Infect Dis. 2017 Aug 3. doi: 10.1093.
    PubMed     Text format     Abstract available


    July 2017
  15. KLEINE CE, Schlabe S, Hischebeth GTR, Molitor E, et al
    Successful therapy of a multi-resistant EBSL (SHV-12)-producing and fluoroquinolone-resistant Salmonella enterica subsp. enterica serovar Typhi infection using combination therapy of meropenem and fosfomycin.
    Clin Infect Dis. 2017 Jul 27. doi: 10.1093.
    PubMed     Text format     Abstract available


  16. KLEIN EY, Mojica N, Jiang W, Cosgrove SE, et al
    Trends in Methicillin-Resistant Staphylococcus aureus Hospitalizations in the United States, 2010-2014.
    Clin Infect Dis. 2017 Jul 26. doi: 10.1093.
    PubMed     Text format     Abstract available


  17. AVERBUCH D, Tridello G, Hoek J, Mikulska M, et al
    Antimicrobial resistance in Gram-negative rods causing bacteremia in hematopoietic stem cell transplant patients: intercontinental prospective study of Infectious Diseases Working Party of the European Bone Marrow Transplantation group.
    Clin Infect Dis. 2017 Jul 26. doi: 10.1093.
    PubMed     Text format     Abstract available


  18. GEISSLER AL, Bustos Carrillo F, Swanson K, Patrick ME, et al
    Increasing Campylobacter Infections, Outbreaks, and Antimicrobial Resistance in the United States, 2004-2012.
    Clin Infect Dis. 2017 Jul 20. doi: 10.1093.
    PubMed     Text format     Abstract available


  19. SCHWABER MJ, Carmeli Y
    The Impact of a Carbapenem-Resistant Enterobacteriaceae Outbreak on Facilitating Development of a National Infrastructure for Infection Control in Israel.
    Clin Infect Dis. 2017 Jul 19. doi: 10.1093.
    PubMed     Text format     Abstract available


  20. FABRE V, Cosgrove SE
    A Coordinated and Sustained Response to the Threat of Antibiotic Resistance Is Critical: Lessons Learned From Israel.
    Clin Infect Dis. 2017 Jul 18. doi: 10.1093.
    PubMed     Text format    


    June 2017
  21. JIMENEZ A, Abbo L, Gebrezgi MT
    Importance of carbapenemase production detection in Carbapenem Resistant Enterobacteriaceae. Looking beyond epidemiological purposes.
    Clin Infect Dis. 2017 Jun 16. doi: 10.1093.
    PubMed     Text format    


    May 2017
  22. LARSEN J, Petersen A, Larsen AR, Sieber RN, et al
    Emergence of livestock-associated methicillin-resistant Staphylococcus aureus bloodstream infections in Denmark.
    Clin Infect Dis. 2017 May 30. doi: 10.1093.
    PubMed     Text format     Abstract available


  23. HOOK EW 3RD
    Continued Evolution of Gonococcal Antimicrobial Resistance.
    Clin Infect Dis. 2017 May 26. doi: 10.1093.
    PubMed     Text format    


  24. CHO SY, Chung DR
    Infection Prevention Strategy in Hospitals in the Era of Community-Associated Methicillin-Resistant Staphylococcus aureus in the Asia-Pacific Region: A Review.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  25. APISARNTHANARAK A, Ratz D, Khawcharoenporn T, Patel PK, et al
    National Survey of Practices to Prevent Methicillin-Resistant Staphylococcus aureus and Multidrug-Resistant Acinetobacter baumannii in Thailand.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  26. MARIMUTHU K, Venkatachalam I, Khong WX, Koh TH, et al
    Clinical and Molecular Epidemiology of Carbapenem-Resistant Enterobacteriaceae Among Adult Inpatients in Singapore.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  27. GANDRA S, Trett A, Klein EY, Laxminarayan R, et al
    Is Antimicrobial Resistance a Bigger Problem in Tertiary Care Hospitals than in Small Community Hospitals in the United States?
    Clin Infect Dis. 2017 May 4. doi: 10.1093.
    PubMed     Text format     Abstract available


  28. TOTH DJA, Khader K, Slayton RB, Kallen AJ, et al
    The potential for interventions in a long-term acute care hospital to reduce transmission of carbapenem-resistant Enterobacteriaceae in affiliated healthcare facilities.
    Clin Infect Dis. 2017 May 3. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2017
  29. RAVEN KE, Gouliouris T, Brodrick H, Coll F, et al
    Complex Routes of Nosocomial Vancomycin-Resistant Enterococcus faecium Transmission Revealed by Genome Sequencing.
    Clin Infect Dis. 2017;64:886-893.
    PubMed     Text format     Abstract available


  30. YANG S, Hemarajata P, Hindler J, Li F, et al
    Evolution and Transmission of Carbapenem-Resistant Klebsiella pneumoniae Expressing the blaOXA-232 Gene During an Institutional Outbreak Associated With Endoscopic Retrograde Cholangiopancreatography.
    Clin Infect Dis. 2017;64:894-901.
    PubMed     Text format     Abstract available


    March 2017
  31. BILINSKI J, Grzesiowski P, Sorensen N, Madry K, et al
    Fecal Microbiota Transplantation in Patients with Blood Disorders Inhibits Gut Colonization with Antibiotic-Resistant Bacteria: Results of a Prospective, Single-Center Study.
    Clin Infect Dis. 2017 Mar 24. doi: 10.1093.
    PubMed     Text format     Abstract available


  32. WEBB BJ, Healy R, Majers J, Burr Z, et al
    Prediction of Bloodstream Infection due to Vancomycin-Resistant Enterococci in Patients Undergoing Leukemia Induction or Hematopoietic Stem Cell Transplantation.
    Clin Infect Dis. 2017 Mar 20. doi: 10.1093.
    PubMed     Text format     Abstract available


  33. VAN HECKE O, Wang K, Lee JJ, Roberts NW, et al
    The implications of antibiotic resistance for patients' recovery from common infections in the community: a systematic review and meta-analysis.
    Clin Infect Dis. 2017 Mar 20. doi: 10.1093.
    PubMed     Text format     Abstract available


  34. TSALIK EL, Petzold E, Kreiswirth BN, Bonomo RA, et al
    Advancing Diagnostics to Address Antibacterial Resistance: The Diagnostics and Devices Committee of the Antibacterial Resistance Leadership Group.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  35. ANDERSON DJ, Jenkins TC, Evans SR, Harris AD, et al
    The Role of Stewardship in Addressing Antibacterial Resistance: Stewardship and Infection Control Committee of the Antibacterial Resistance Leadership Group.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  36. DOI Y, Bonomo RA, Hooper DC, Kaye KS, et al
    Gram-Negative Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  37. DOERNBERG SB, Lodise TP, Thaden JT, Munita JM, et al
    Gram-Positive Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  38. HUVANE J, Komarow L, Hill C, Tran TT, et al
    Fundamentals and Catalytic Innovation: The Statistical and Data Management Center of the Antibacterial Resistance Leadership Group.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  39. MANCA C, Hill C, Hujer AM, Patel R, et al
    Leading Antibacterial Laboratory Research by Integrating Conventional and Innovative Approaches: The Laboratory Center of the Antibacterial Resistance Leadership Group.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  40. CROSS HR, Harris A, Arias RM, Chambers HF, et al
    Transforming Concepts Into Clinical Trials and Creating a Multisite Network: The Leadership and Operations Center of the Antibacterial Resistance Leadership Group.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  41. CHAMBERS HF, Cross HR, Evans SR, Kreiswirth BN, et al
    The Antibacterial Resistance Leadership Group: Progress Report and Work in Progress.
    Clin Infect Dis. 2017;64.
    PubMed     Text format     Abstract available


  42. MURRAY BE, Jezek A
    The Antibacterial Resistance Leadership Group: First Steps.
    Clin Infect Dis. 2017;64.
    PubMed     Text format    


  43. MUNITA JM, Aitken SL, Miller WR, Perez F, et al
    Multicenter Evaluation of Ceftolozane/Tazobactam for Serious Infections Caused by Carbapenem-Resistant Pseudomonas aeruginosa.
    Clin Infect Dis. 2017 Mar 14. doi: 10.1093.
    PubMed     Text format     Abstract available


  44. HOFSTRA LM, Sanchez Rivas E, Nijhuis M, Bank LE, et al
    High Rates of Transmission of Drug-resistant HIV in Aruba Resulting in Reduced Susceptibility to the WHO Recommended First-line Regimen in Nearly Half of Newly Diagnosed HIV-infected Patients.
    Clin Infect Dis. 2017 Mar 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  45. COLLINS IJ, Foster C, Tostevin A, Tookey P, et al
    Clinical Status of Adolescents with Perinatal HIV at Transfer to Adult Care in the UK/Ireland.
    Clin Infect Dis. 2017 Mar 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  46. SEE I, Wesson P, Gualandi N, Dumyati G, et al
    Socioeconomic Factors Explain Racial Disparities in Invasive Community-Associated Methicillin-Resistant Staphylococcus aureus Disease Rates.
    Clin Infect Dis. 2017;64:597-604.
    PubMed     Text format     Abstract available


    February 2017
  47. THOMPSOM CN, Karkey A, Dongol S, Ariyal A, et al
    Treatment response in enteric fever in an era of increasing antimicrobial resistance: an individual patient data analysis of 2,092 participants enrolled into four randomised controlled trials in Nepal.
    Clin Infect Dis. 2017 Feb 28. doi: 10.1093.
    PubMed     Text format     Abstract available


  48. KIZNY GORDON AE, Mathers AJ, Cheong EY, Gottlieb T, et al
    Is the hospital water environment a reservoir for carbapenem-resistant organisms causing hospital-acquired infections? A systematic review of the literature.
    Clin Infect Dis. 2017 Feb 13. doi: 10.1093.
    PubMed     Text format    


  49. ROHDE AM, Gastmeier P
    Optimizing Proton Pump Inhibitor Use to Reduce Antimicrobial Resistance Rates?
    Clin Infect Dis. 2017 Feb 4. doi: 10.1093.
    PubMed     Text format    


  50. KOH WJ, Jeong BH, Kim SY, Jeon K, et al
    Mycobacterial Characteristics and Treatment Outcomes in Mycobacterium abscessus Lung Disease.
    Clin Infect Dis. 2017;64:309-316.
    PubMed     Text format     Abstract available


  51. READ TR, Fairley CK, Tabrizi SN, Bissessor M, et al
    Azithromycin 1.5g Over 5 Days Compared to 1g Single Dose in Urethral Mycoplasma genitalium: Impact on Treatment Outcome and Resistance.
    Clin Infect Dis. 2017;64:250-256.
    PubMed     Text format     Abstract available


  52. PATEL R, Tsalik EL, Petzold E, Fowler VG Jr, et al
    MASTERMIND: Bringing Microbial Diagnostics to the Clinic.
    Clin Infect Dis. 2017;64:355-360.
    PubMed     Text format     Abstract available


  53. MOEHRING RW, Anderson DJ, Cochran RL, Hicks LA, et al
    Expert Consensus on Metrics to Assess the Impact of Patient-Level Antimicrobial Stewardship Interventions in Acute-Care Settings.
    Clin Infect Dis. 2017;64:377-383.
    PubMed     Text format     Abstract available


    January 2017
  54. CHUANG YC, Lin HY, Chen PY, Lin CY, et al
    Effect of Daptomycin Dose on the Outcome of Vancomycin-Resistant, Daptomycin-Susceptible Enterococcus faecium Bacteremia.
    Clin Infect Dis. 2017 Jan 25. doi: 10.1093.
    PubMed     Text format     Abstract available


    December 2016
  55. HAN JH, Goldstein EJ, Wise J, Bilker WB, et al
    Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae in a Network of Long-Term Acute Care Hospitals.
    Clin Infect Dis. 2016 Dec 24. pii: ciw856. doi: 10.1093.
    PubMed     Text format     Abstract available


  56. BRITT NS, Potter EM, Patel N, Steed ME, et al
    Comparative Effectiveness and Safety of Standard-, Medium-, and High-Dose Daptomycin Strategies for the Treatment of Vancomycin-Resistant Enterococcal Bacteremia Among Veterans Affairs Patients.
    Clin Infect Dis. 2016 Dec 22. pii: ciw815. doi: 10.1093.
    PubMed     Text format     Abstract available


  57. ROJAS LJ, Salim M, Cober E, Richter SS, et al
    Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  58. VINNARD C, King L, Munsiff S, Crossa A, et al
    The Long-Term Mortality of Tuberculosis Meningitis Patients in New York City: A Cohort Study.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


    November 2016
  59. GOMEZ CA, Deresinski S
    Treatment of Hospital or Ventilator-Associated Pneumonia Due to Carbapenem-Resistant Enterobacteriaceae: Leveraging Molecular Resistance Testing and Combination Therapy to Improve Outcomes.
    Clin Infect Dis. 2016;63:1395-1396.
    PubMed     Text format    


  60. TAMMA PD, Goodman KE, Harris AD, Tekle T, et al
    Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia.
    Clin Infect Dis. 2016 Nov 9. pii: ciw741. doi: 10.1093.
    PubMed     Text format     Abstract available


    October 2016
  61. FETSCH A, Kraushaar B, Kasbohrer A, Hammerl JA, et al
    Turkey Meat as Source of CC9/CC398 Methicillin-Resistant Staphylococcus aureus in Humans?
    Clin Infect Dis. 2016.
    PubMed     Text format    


  62. BROWN L, Langelier C, Reid MJ, Rutishauser RL, et al
    Antimicrobial Resistance: A Call to Action!
    Clin Infect Dis. 2016.
    PubMed     Text format    


    September 2016
  63. TREMBIZKI E, Wand H, Donovan B, Chen M, et al
    The molecular epidemiology and antimicrobial resistance of Neisseria gonorrhoeae in Australia: a nationwide cross-sectional study, 2012.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  64. LARSEN J, Stegger M, Andersen PS, Petersen A, et al
    Evidence for Human Adaptation and Foodborne Transmission of Livestock-Associated Methicillin-Resistant Staphylococcus aureus.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  65. SHIELDS RK, Potoski BA, Haidar G, Hao B, et al
    Clinical outcomes, drug toxicity and emergence of ceftazidime-avibactam resistance among patients treated for carbapenem-resistant Enterobacteriaceae infections.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  66. SPELLBERG B, Bonomo RA
    Ceftazidime-Avibactam and Carbapenem-Resistant Enterobacteriaceae: "We're Gonna Need a Bigger Boat".
    Clin Infect Dis. 2016.
    PubMed     Text format    


    August 2016
  67. SCIARRETTA K, Rottingen JA, Opalska A, Van-Hengel AJ, et al
    Economic Incentives for Antibacterial Drug Development: Literature Review and Considerations from the Transatlantic Task Force on Antimicrobial Resistance.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  68. GREBELY J, Dore GJ, Zeuzem S, Aspinall RJ, et al
    Efficacy and safety of sofosbuvir/velpatasvir in patients with chronic hepatitis C virus infection receiving opioid substitution therapy: Analysis of Phase 3 ASTRAL trials.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  69. RAY MJ, Lin MY, Weinstein RA, Trick WE, et al
    Spread of Carbapenem-Resistant Enterobacteriaceae Among Illinois Healthcare Facilities: The Role of Patient Sharing.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


    July 2016
  70. COLLIGNON PC, Conly JM, Andremont A, McEwen SA, et al
    World Health Organization Ranking of Antimicrobials According to their Importance in Human Medicine: A Critical Step for Developing Risk Management Strategies to Control Antimicrobial Resistance from Food Animal Production.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  71. WU G, Abraham T, Lee S
    Ceftazidime-avibactam for treatment of carbapenem-resistant Enterobacteriaceae bacteremia.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  72. CHALMERS JD, Reyes LF, Aliberti S, Restrepo MI, et al
    Empirical Coverage of Methicillin-Resistant Staphylococcus aureus in Community-Acquired Pneumonia: Those Who Do Not Remember the Past Are Doomed to Repeat It.
    Clin Infect Dis. 2016.
    PubMed     Text format    


    June 2016
  73. JOUHTEN H, Mattila E, Arkkila P, Satokari R, et al
    Reduction of antibiotic resistance genes in intestinal microbiota of recurrent Clostridium difficile patients after fecal microbiota transplantation.
    Clin Infect Dis. 2016.
    PubMed     Text format    


    May 2016
  74. FATKENHEUER G, Jung N
    Treatment of Asymptomatic Bacteriuria.
    Clin Infect Dis. 2016;62:1190.
    PubMed     Text format    


  75. CAI T, Bartoletti R
    Reply to Fatkenheuer and Jung.
    Clin Infect Dis. 2016;62:1191.
    PubMed     Text format    


    April 2016
  76. KARANIKA S, Kinamon T, Grigoras C, Mylonakis E, et al
    Colonization with Methicillin-Resistant Staphylococcus aureus and Risk for Infection among Asymptomatic Athletes: A Systematic Review and Meta-Analysis.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  77. DATE KA, Newton AE, Medalla F, Blackstock A, et al
    Changing Patterns in Enteric Fever Incidence and Increasing Antibiotic Resistance of Enteric Fever Isolates in the United States, 2008-2012.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  78. MANCINI N, Clementi N, Burioni R, Clementi M, et al
    Rational Dosing Strategies of Colistin: What About Resistance?
    Clin Infect Dis. 2016;62:1054.
    PubMed     Text format    


    March 2016
  79. MILLAN B, Park H, Hotte N, Mathieu O, et al
    Fecal microbial transplants reduce antibiotic-resistant genes in patients with recurrent Clostridium difficile infection.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  80. HALPIN AL, McDonald LC
    The Dawning of Microbiome Remediation for Addressing Antibiotic Resistance.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  81. MUNOZ-PRICE LS, Frencken JF, Tarima S, Bonten M, et al
    Handling time dependent variables: antibiotics and antibiotic resistance.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  82. PHILLIPS PP, Morris TP, Walker AS
    DOOR/RADAR: A Gateway Into the Unknown?
    Clin Infect Dis. 2016;62:814-5.
    PubMed     Text format    


  83. EVANS S, Follmann D, Schoenfeld D, Fowler VG Jr, et al
    Reply to Phillips, Morris, and Walker.
    Clin Infect Dis. 2016;62:815-6.
    PubMed     Text format    


  84. IM J, Nichols C, Bjerregaard-Andersen M, Sow AG, et al
    Prevalence of Salmonella Excretion in Stool: A Community Survey in 2 Sites, Guinea-Bissau and Senegal.
    Clin Infect Dis. 2016;62 Suppl 1:S50-5.
    PubMed     Text format     Abstract available


  85. AL-EMRAN HM, Heisig A, Dekker D, Adu-Sarkodie Y, et al
    Detection of a Novel gyrB Mutation Associated With Fluoroquinolone-Nonsusceptible Salmonella enterica serovar Typhimurium Isolated From a Bloodstream Infection in Ghana.
    Clin Infect Dis. 2016;62 Suppl 1:S47-9.
    PubMed     Text format     Abstract available


  86. AL-EMRAN HM, Eibach D, Krumkamp R, Ali M, et al
    A Multicountry Molecular Analysis of Salmonella enterica Serovar Typhi With Reduced Susceptibility to Ciprofloxacin in Sub-Saharan Africa.
    Clin Infect Dis. 2016;62 Suppl 1:S42-6.
    PubMed     Text format     Abstract available


  87. STEELE AD, Hay Burgess DC, Diaz Z, Carey ME, et al
    Challenges and Opportunities for Typhoid Fever Control: A Call for Coordinated Action.
    Clin Infect Dis. 2016;62 Suppl 1:S4-8.
    PubMed     Text format     Abstract available


  88. EIBACH D, Al-Emran HM, Dekker DM, Krumkamp R, et al
    The Emergence of Reduced Ciprofloxacin Susceptibility in Salmonella enterica Causing Bloodstream Infections in Rural Ghana.
    Clin Infect Dis. 2016;62 Suppl 1:S32-6.
    PubMed     Text format     Abstract available


  89. SEE I, Freifeld AG, Magill SS
    Causative Organisms and Associated Antimicrobial Resistance in Healthcare-Associated Central Line-Associated Bloodstream Infections from Oncology Settings, 2009-2012.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  90. VAN BAMBEKE F, Tulkens PM
    Editorial Commentary: Colistin and a New Paradigm in Drug Development.
    Clin Infect Dis. 2016;62:559-60.
    PubMed     Text format    


    February 2016
  91. SOLOMKIN JS, Hershberger E, Eckmann C
    Response to Spellberg and Brass.
    Clin Infect Dis. 2016;62:526.
    PubMed     Text format    


  92. SPELLBERG B, Brass EP
    Noninferiority Doesn't Mean Not Inferior.
    Clin Infect Dis. 2016;62:525-6.
    PubMed     Text format    


  93. DETJEN AK, Walters E
    Improving Children's Access to New Tuberculosis Diagnostic Tools Starts With the Collection of Appropriate Specimens.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  94. TOMCZYK SM, Lynfield R, Schaffner W, Reingold A, et al
    Prevention of antibiotic-nonsusceptible invasive pneumococcal disease with the 13-valent pneumococcal conjugate vaccine.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  95. DENG X, Peirano G, Schillberg E, Mazzulli T, et al
    Whole-Genome Sequencing Reveals the Origin and Rapid Evolution of an Emerging Outbreak Strain of Streptococcus pneumoniae 12F.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  96. FIRNHABER C, Kendall MA, Wu X, Mazurek GH, et al
    Evaluation of Xpert MTB/RIF to identify pulmonary tuberculosis in tuberculosis suspects from low and higher prevalence settings compared to acid fast smear and culture.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


  97. FRIPPIAT F, Vercheval C, Layios N
    Decreased Antibiotic Consumption in the Belgian Community: Is It Credible?
    Clin Infect Dis. 2016;62:403-4.
    PubMed     Text format    


    January 2016
  98. IDELEVICH EA, Becker K
    Identification and Susceptibility Testing From Shortly Incubated Cultures Accelerate Blood Culture Diagnostics at No Cost.
    Clin Infect Dis. 2016;62:268-9.
    PubMed     Text format    


  99. BANERJEE R, Teng CB, Cunningham SA, Ihde S, et al
    Reply to Idelevich and Beck.
    Clin Infect Dis. 2016;62:269-70.
    PubMed     Text format    


  100. EVANS SR, Hujer AM, Jiang H, Hujer KM, et al
    Rapid Molecular Diagnostics, Antibiotic Treatment Decisions, and Developing Approaches to Inform Empiric Therapy: PRIMERS I and II.
    Clin Infect Dis. 2016;62:181-9.
    PubMed     Text format     Abstract available


  101. QURESHI AI, Chughtai M, Loua TO, Kolie JP, et al
    Reply to Nanyonga et al.
    Clin Infect Dis. 2016;62:126.
    PubMed     Text format    


  102. OLANS RN, Olans RD, DeMaria A Jr
    The Critical Role of the Staff Nurse in Antimicrobial Stewardship--Unrecognized, but Already There.
    Clin Infect Dis. 2016;62:84-9.
    PubMed     Text format     Abstract available


    December 2015
  103. TABAH A, Cotta MO, Garnacho-Montero J, Schouten J, et al
    A systematic review of the definitions, determinants and clinical outcomes of antimicrobial de-escalation in the intensive care unit.
    Clin Infect Dis. 2015 Dec 23. pii: civ1199.
    PubMed     Text format     Abstract available


  104. LANE CR, Sutton B, Valcanis M, Kirk M, et al
    Travel destinations and sexual behavior as indicators of antibiotic resistant Shigella strains - Victoria, Australia.
    Clin Infect Dis. 2015 Dec 17. pii: civ1018.
    PubMed     Text format     Abstract available


  105. MEITES E, Gaydos CA, Hobbs MM, Kissinger P, et al
    A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections.
    Clin Infect Dis. 2015;61 Suppl 8:S837-48.
    PubMed     Text format     Abstract available


  106. HETEM DJ, Bootsma MC, Bonten MJ
    Prevention of surgical site infections: decontamination with mupirocin based on pre-operative screening for Staphylococcus aureus carriers or universal decontamination?
    Clin Infect Dis. 2015.
    PubMed     Text format     Abstract available


  107. GHANNOUM M, Roilides E, Katragkou A, Petraitis V, et al
    The Role of Echinocandins in Candida Biofilm-Related Vascular Catheter Infections: In Vitro and In Vivo Model Systems.
    Clin Infect Dis. 2015;61 Suppl 6:S618-21.
    PubMed     Text format     Abstract available


  108. PERLIN DS
    Echinocandin Resistance in Candida.
    Clin Infect Dis. 2015;61 Suppl 6:S612-7.
    PubMed     Text format     Abstract available


    November 2015
  109. HOFSTRA LM, Sauvageot N, Albert J, Alexiev I, et al
    Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe.
    Clin Infect Dis. 2015.
    PubMed     Text format     Abstract available


  110. BUSS BA, Schulz LT, Reed KD, Fox BC, et al
    MALDI-TOF utility in a region with low antibacterial resistance rates.
    Clin Infect Dis. 2015.
    PubMed     Text format    


  111. MILLOY MJ, Wood E, Kerr T, Hogg B, et al
    Increased prevalence of controlled viremia and decreased rates of HIV drug resistance among HIV-positive people who use illicit drugs during a community-wide Treatment-as-Prevention initiative.
    Clin Infect Dis. 2015.
    PubMed     Text format     Abstract available


  112. MANDOMANDO I, Bassat Q, Sigauque B, Massora S, et al
    Invasive Salmonella Infections Among Children From Rural Mozambique, 2001-2014.
    Clin Infect Dis. 2015;61 Suppl 4:S339-45.
    PubMed     Text format     Abstract available


  113. KARIUKI S, Onsare RS
    Epidemiology and Genomics of Invasive Nontyphoidal Salmonella Infections in Kenya.
    Clin Infect Dis. 2015;61 Suppl 4:S317-24.
    PubMed     Text format     Abstract available


  114. ONEKO M, Kariuki S, Muturi-Kioi V, Otieno K, et al
    Emergence of Community-Acquired, Multidrug-Resistant Invasive Nontyphoidal Salmonella Disease in Rural Western Kenya, 2009-2013.
    Clin Infect Dis. 2015;61 Suppl 4:S310-6.
    PubMed     Text format     Abstract available


  115. MUTHUMBI E, Morpeth SC, Ooko M, Mwanzu A, et al
    Invasive Salmonellosis in Kilifi, Kenya.
    Clin Infect Dis. 2015;61 Suppl 4:S290-301.
    PubMed     Text format     Abstract available


  116. KEDDY KH, Sooka A, Musekiwa A, Smith AM, et al
    Clinical and Microbiological Features of Salmonella Meningitis in a South African Population, 2003-2013.
    Clin Infect Dis. 2015;61 Suppl 4:S272-82.
    PubMed     Text format     Abstract available


    October 2015
  117. CEGIELSKI JP, Kurbatova E, van der Walt M, Brand J, et al
    Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment, Initial and Acquired Second-Line Drug Resistance.
    Clin Infect Dis. 2015.
    PubMed     Text format     Abstract available


  118. VERWEIJ PE, Chowdhary A, Melchers WJ, Meis JF, et al
    Azole resistance in Aspergillus fumigatus: can we retain the clinical use of mold-active antifungal azoles?
    Clin Infect Dis. 2015.
    PubMed     Text format     Abstract available


  119. KNIGHT GM, Colijn C, Shrestha S, Fofana M, et al
    The Distribution of Fitness Costs of Resistance-Conferring Mutations Is a Key Determinant for the Future Burden of Drug-Resistant Tuberculosis: A Model-Based Analysis.
    Clin Infect Dis. 2015;61Suppl 3:S147-54.
    PubMed     Text format     Abstract available


  120. STARKS AM, Aviles E, Cirillo DM, Denkinger CM, et al
    Collaborative Effort for a Centralized Worldwide Tuberculosis Relational Sequencing Data Platform.
    Clin Infect Dis. 2015;61Suppl 3:S141-6.
    PubMed     Text format     Abstract available


    September 2015
  121. BUTI M, Gordon SC, Zuckerman E, Lawitz E, et al
    Grazoprevir, Elbasvir, and Ribavirin for Chronic Hepatitis C Virus Genotype 1 Infection After Failure of Pegylated Interferon and Ribavirin With an Earlier-Generation Protease Inhibitor: Final 24-Week Results From C-SALVAGE.
    Clin Infect Dis. 2015.
    PubMed     Text format     Abstract available


  122. EVANS SR, Rubin D, Follmann D, Pennello G, et al
    Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR).
    Clin Infect Dis. 2015;61:800-6.
    PubMed     Text format     Abstract available


  123. MOLINA J, Cisneros JM
    Editorial Commentary: A Chance to Change the Paradigm of Outcome Assessment of Antimicrobial Stewardship Programs.
    Clin Infect Dis. 2015;61:807-8.
    PubMed     Text format    


  124. GELFAND MS, Cleveland KO
    Ceftolozane/Tazobactam Therapy of Respiratory Infections due to Multidrug-Resistant Pseudomonas aeruginosa.
    Clin Infect Dis. 2015;61:853-5.
    PubMed     Text format    


    August 2015
  125. GUMBO T, Pasipanodya JG, Nuermberger E, Romero K, et al
    Correlations Between the Hollow Fiber Model of Tuberculosis and Therapeutic Events in Tuberculosis Patients: Learn and Confirm.
    Clin Infect Dis. 2015;61 Suppl 1:S18-24.
    PubMed     Text format     Abstract available


  126. BOENDER TS, Hoenderboom BM, Sigaloff KC, Hamers RL, et al
    Pretreatment HIV Drug Resistance Increases Regimen Switches in Sub-Saharan Africa.
    Clin Infect Dis. 2015.
    PubMed     Text format     Abstract available


    June 2015
  127. GOTTIG S, Gruber TM, Stecher B, Wichelhaus TA, et al
    In vivo horizontal gene transfer of the carbapenemase OXA-48 during a nosocomial outbreak.
    Clin Infect Dis. 2015;60:1808-15.
    PubMed     Text format     Abstract available


    May 2015
  128. TONG CY, Costelloe S, Hubb J, Mullen J, et al
    Deep sequencing of HIV-1 in cerebrospinal fluid.
    Clin Infect Dis. 2015.
    PubMed     Text format     Abstract available


  129. MBISA JL, Fearnhill E, Dunn DT, Pillay D, et al
    Evidence of self-sustaining drug resistant HIV-1 lineages among untreated patients in the UK.
    Clin Infect Dis. 2015.
    PubMed     Text format     Abstract available


  130. KOUYOS R, Gunthard HF
    The irreversibility of HIV drug resistance.
    Clin Infect Dis. 2015.
    PubMed     Text format    


  131. SOLOMKIN J, Hershberger E, Miller B, Popejoy M, et al
    Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI).
    Clin Infect Dis. 2015;60:1462-71.
    PubMed     Text format     Abstract available


  132. GAFFIN N
    Reflections from an antimicrobial stewardship program.
    Clin Infect Dis. 2015;60:1588-9.
    PubMed     Text format    


  133. GOLDSTEIN EJ, Tyrrell KL, Citron DM
    Lactobacillus species: taxonomic complexity and controversial susceptibilities.
    Clin Infect Dis. 2015;60 Suppl 2:S98-107.
    PubMed     Text format     Abstract available


  134. LUKAC PJ, Bonomo RA, Logan LK
    Extended-spectrum beta-lactamase-producing Enterobacteriaceae in children: old foe, emerging threat.
    Clin Infect Dis. 2015;60:1389-97.
    PubMed     Text format     Abstract available


    April 2015
  135. WARDYN SE, Forshey BM, Farina SA, Kates AE, et al
    Swine Farming Is a Risk Factor for Infection With and High Prevalence of Carriage of Multidrug-Resistant Staphylococcus aureus.
    Clin Infect Dis. 2015.
    PubMed     Text format     Abstract available


  136. LISS MA, Johnson JR, Porter SB, Johnston B, et al
    Clinical and microbiological determinants of infection after transrectal prostate biopsy.
    Clin Infect Dis. 2015;60:979-87.
    PubMed     Text format     Abstract available


    March 2015
  137. MADIGAN T, Johnson JR, Clabots C, Johnston BD, et al
    Extensive household outbreak of urinary tract infection and intestinal colonization due to extended-spectrum beta lactamase (ESBL)-producing Escherichia coli sequence type 131 (ST131).
    Clin Infect Dis. 2015.
    PubMed     Text format     Abstract available


    February 2015
  138. DESCAMPS D, Peytavin G, Visseaux B, Tubiana R, et al
    Dolutegravir in HIV-2 infected patients with resistant virus to first-line integrase inhibitors from the French Named Patient Program.
    Clin Infect Dis. 2015.
    PubMed     Text format     Abstract available


  139. KANTOR R, Smeaton L, Vardhanabhuti S, Hudelson SE, et al
    Pre-Treatment HIV Drug Resistance and HIV-1 Subtype C are Independently Associated with Virologic Failure: Results from the Multi-national PEARLS (ACTG A5175) Clinical Trial.
    Clin Infect Dis. 2015.
    PubMed     Text format     Abstract available


  140. WAINBERG MA
    The Clinical Significance of HIV Subtype Variability in Regard to Treatment Outcome.
    Clin Infect Dis. 2015.
    PubMed     Text format    


    January 2015
  141. ROGO T, DeLong AK, Chan P, Kantor R, et al
    Antiretroviral Treatment Failure, Drug resistance and Subtype Diversity in the only Pediatric HIV Clinic in Rhode Island.
    Clin Infect Dis. 2015.
    PubMed     Text format     Abstract available


    May 2014
  142. WALLIS C, Aga E, Ribaudo H, Saravanan S, et al
    Drug Susceptibility and Resistance Mutations after First-Line Failure in Resource Limited Settings.
    Clin Infect Dis. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: